Последно актуализиране :
19/11/2024
Infostab
Списък с лекарства
Съдържание
Потърсете съвместимост
Таблица за съвместимост на Y-сайта
Библиография
Изследователски екипи
valistab
Плакат
звена
спонсори
Автори
Ръководство за потребителя
Бюлетин
Tacrolimus
Химична структура
Библиография : Tacrolimus
Вид
Публикация
2436
Списание
Jacobson PA, Johnson CE, West NJ, Foster JA.
Stability of tacrolimus in an extemporaneously compounded oral liquid
Am J Health-Syst Pharm 1997 ; 54: 178-180.
2789
Списание
Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, McCarthy PL.
Long-term stability of a patient-convenient 1mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels.
Bone Marrow Transplantation 2006 ; 37, 8: 781-784.
3846
Списание
Polonini HC, Silva SL, Cunha CN, Brand?o MAF, Ferreira AO.
Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend® SF PH4 oral suspensions.
Pharmazie 2016 71: 185?191.
3946
Списание
Friciu M, Zaraa S, Leclair G.
Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes
Can J Hosp Pharm 2017 ; 70,1 :51-53.
4177
Списание
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526
4673
Списание
Barrieu M, Chennell P, Yessaad M, Bouattour Y, Wasiak M, Jouannet M, Le Basle Y, Sautou V.
Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases.
Pharmaceutics 2022 ;14,1:118
Mentions Légales
